Bellevue Centre
Suite 300 235 -15th Street
West Vancouver, BC V7T 2X1
Canada
604-921-1810
https://briacell.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 16
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. William V. Williams M.D. | CEO, President & Director | 1.06M | N/A | 1955 |
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. | CFO & Corporate Secretary | 409.48k | N/A | 1973 |
Dr. Miguel A. Lopez-Lago Ph.D. | Chief Scientific Officer | 401.99k | N/A | 1969 |
Dr. Giuseppe Del Priore M.D., M.P.H., MPH | Chief Medical Officer | 662.37k | N/A | 1962 |
Dr. Charles Louis Wiseman FACP, M.D. | Founder, Principal Research Advisor & Member of Scientific Advisory Board | 324.31k | N/A | 1946 |
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.